Our esteemed collaborators, Kalien M. from Stanford University School of Medicine, and Tim W. from Washington University School of Medicine in St. Louis presented leading-edge studies utilizing PMD-026. Their research underscores promising data supporting the efficacy of PMD-026 in treating myeloid cancers, including Acute Myeloid Leukemia (AML).
Back to All Events
Earlier Event: December 7
San Antonio Breast Cancer Symposium 2023
Later Event: January 6
Longwood Healthcare Leaders San Francisco CEO Conference